Agreed, RV, it is not a hard commitment if said on
Post# of 36537
(Total Views: 472)
Posted On: 08/10/2021 10:37:35 PM
Agreed, RV, it is not a hard commitment if said on a conference call.
But it would give Joe the chance to explain why he won’t be updating us or give us the chance to call him out in the future if he chooses not to tell us something he tells her s Loyal Shareholders he will inform us about.
In my example w the IND date, I would be a lot happier right now if I had posed this question to Joe in the Q&A of the last call, and he had stated something like this:
“Well, the IND is a very complex submittal, and we are going to put all our efforts into it. As I said before, we will have the production run completed on 5/18, and the stability testing will take 6-8 weeks. After that, we will compile the data and zip up the IND and get it submitted, maybe in 2 or 3 weeks.
However, the submittal itself is not the news, the approval is. So as much as I know you all want to hear about the submittal date, we will most likely work through any feedback we get from the FDA and let everyone know when we pass the real milestone, which again is the APPROVAL of the IND.”
Would that be so hard to convey to us?
Instead, we guess, suppose, surmise, extrapolate, assume, and do anything we can to make sense of silence. All the while, in our minds, we were “due” an update. But maybe Joe never was considering updating us. Time goes by, there’s more dilution plus a slow exit of “loyal shareholders”, and we see the price continue to drop (leading to escalating dilution if there is a need for cash).
It never hurts to ask. We just need to start asking better and more specific Qs on details like this when we have the chance.
All that said, I concur that a well thought out PR or two would be preferable to a CC announcement for late September.
Info please…
But it would give Joe the chance to explain why he won’t be updating us or give us the chance to call him out in the future if he chooses not to tell us something he tells her s Loyal Shareholders he will inform us about.
In my example w the IND date, I would be a lot happier right now if I had posed this question to Joe in the Q&A of the last call, and he had stated something like this:
“Well, the IND is a very complex submittal, and we are going to put all our efforts into it. As I said before, we will have the production run completed on 5/18, and the stability testing will take 6-8 weeks. After that, we will compile the data and zip up the IND and get it submitted, maybe in 2 or 3 weeks.
However, the submittal itself is not the news, the approval is. So as much as I know you all want to hear about the submittal date, we will most likely work through any feedback we get from the FDA and let everyone know when we pass the real milestone, which again is the APPROVAL of the IND.”
Would that be so hard to convey to us?
Instead, we guess, suppose, surmise, extrapolate, assume, and do anything we can to make sense of silence. All the while, in our minds, we were “due” an update. But maybe Joe never was considering updating us. Time goes by, there’s more dilution plus a slow exit of “loyal shareholders”, and we see the price continue to drop (leading to escalating dilution if there is a need for cash).
It never hurts to ask. We just need to start asking better and more specific Qs on details like this when we have the chance.
All that said, I concur that a well thought out PR or two would be preferable to a CC announcement for late September.
Info please…
(2)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼